I was just looking at EXL's quarterly report, the level of professionalism they have is what AC8 is needing, we are a company with the cash, already have the licenses but no progress or action plan being told to the shareholders.
Look at this excerpt from EXLs latest quarterly
"Elixinol Australia’s licence submissions for the cultivation and manufacturing of medicinal cannabis continue to be under review by the Office of Drug Control (ODC).
Although the Company remains optimistic that it will receive both cultivation and manufacturing licences, it is nevertheless disappointing that the ODC is unable to provide any timing on the granting of both licences. The Development Application (DA) for the Company’s integrated cultivation and manufacture facility is under review by the Byron Shire Municipal Council.
The comprehensive operational plan for the facility is completed and a project manager has been appointed to oversee the construction of the facility. Upon receipt of the cultivation and manufacturing licences, focus will be on the construction of the Company’s state of the art facility."
EXL dont even have the licenses like AC8 and seem to be more ready than AC8, AC8 has great opps here to be the big player in Australia but we need to get some professionalism and action plans in place and communicated to the market.
- Forums
- ASX - By Stock
- AC8
- where to next?
where to next?, page-802
-
- There are more pages in this discussion • 1,014 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add AC8 (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
LPM
LITHIUM PLUS MINERALS LTD.
Simon Kidston, Non--Executive Director
Simon Kidston
Non--Executive Director
SPONSORED BY The Market Online